Europe Developing New Cruise Missile Planned for Testing in Ukraine, Destinus Says

What happened

New Voice Ukraine reports that European aerospace company Destinus and German defense conglomerate Rheinmetall are accelerating the development of a new cruise missile named Ruta Block 3, which they state is planned to be tested in Ukraine.

The central claim remains unconfirmed in the supplied material and should be treated as hearsay until corroborated by another reliable source or a named official. The announcement came from Destinus on May 18, outlining the companies' intention to advance the missile's development and conduct trials on Ukrainian soil. The source does not specify the timeline for testing or operational deployment.

The significance of this claim lies in the potential introduction of advanced missile capabilities in the Russia-Ukraine conflict, which could influence military balance or provoke strategic responses from involved parties.

Known from the source

• Destinus and Rheinmetall are reportedly accelerating development of a cruise missile called Ruta Block 3.
• Destinus announced plans on May 18 to test the missile in Ukraine.
• The report is from New Voice Ukraine, a local English public source.

What remains unclear

As the source provides only the companies' stated plans without independent confirmation or details of Ukrainian government involvement, the information remains unverified outside the original announcement.

What remains unclear: Confirm whether the central claim is corroborated; until then treat it as unconfirmed/hearsay. Whether the missile testing in Ukraine has official approval or has commenced. Any independent verification of the missile's development progress and deployment plans. Clarify the involvement of Ukrainian authorities in the planned testing.

Evidence note

This story contains report-led claims. The article keeps those claims attributed and treats them as unconfirmed/hearsay unless independently corroborated.

Original source: New Voice Ukraine. Open the source.